Page last updated: 2024-09-05

quizalofop and cytarabine

quizalofop has been researched along with cytarabine in 1 studies

Compound Research Comparison

Studies
(quizalofop)
Trials
(quizalofop)
Recent Studies (post-2010)
(quizalofop)
Studies
(cytarabine)
Trials
(cytarabine)
Recent Studies (post-2010) (cytarabine)
2501715,4872,4243,188

Protein Interaction Comparison

ProteinTaxonomyquizalofop (IC50)cytarabine (IC50)
nuclear receptor coactivator 3 isoform aHomo sapiens (human)7.533
E3 ubiquitin-protein ligase Mdm2Homo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corbett, TH; Edelstein, M; Hazeldine, ST; Horwitz, JP; Kushner, J; Palomino, E; Paluch, J; Polin, L; White, K1

Other Studies

1 other study(ies) available for quizalofop and cytarabine

ArticleYear
Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).
    Journal of medicinal chemistry, 2001, May-24, Volume: 44, Issue:11

    Topics: Animals; Antineoplastic Agents; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Quinoxalines; Stereoisomerism; Structure-Activity Relationship; Transplantation, Heterologous; Tumor Cells, Cultured

2001